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1. INTRODUCTION 
The leukotriencs as members of the cicosanoid Famb 
ly of madiacors are most biologically active substances 
eliciting inflammatory and allergic reactions [l-5], In a 
limited number of cell types, e.g. mast cells, eosino- 
phils, monocytes, neutrophils, and macrophages, the 
formation of lcukorriencs is initiated by liberation of 
arachidonate from membrane phospholipids and by the 
synthesis of LTkr which is converted ta LTB4 or to the 
glutathione conjugate LX,. Most actions of the 
leukotricnes are exerted from the extracellular space. 
Leukotriene transport across the plasma membrane 
[6,-I] is therefore a prerequisite for expression of their 
biological activities through the interaction with recep- 
tors [SJ. 
The present study deals with the mechanism underly- 
ing the membrane transport of LTC4 and LTB4 in 
leukotriene-producing cells. The formation of 
leukotrienes i  particularly active in mastocytoma cehs, 
the source from which LTQ was first isolated [9]. Us- 
ing plasma membrane vesicles from mouse 
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moscocytoma cells we present evidence for the existence 
of an ATP-dependent export system responsible for the 
release of LTCd (Fig. 1) as well as LTB4. 
2. MATERIALS AND METHODS 
ATP, crcntine phosphate, crcatine kinase, and phenylmethylsul- 
fonylfluoridc were obtained from Bocbringcr Mannhcim (Mann- 
IlPim, Germany). [5,6,8,9,11,12,14,15-‘HsJArachidonic acid, 
14, IS.“H&belcd LTQ4, o.OH.LTB4, LTC4, LTD4, and LTEr were 
purchased from DuPont-New England Nuclear (Roston, MA, USA), 
[‘H]wCOOH-LTB4 was synthesized from (‘H]w-OH-LTB4 and kind” 
ly provided by 0. Jedlitschky from our laboratory [IO]. 
Fig. 1, Scheme of biosynthesis and ATP-dependent export 
from lenkotriene-generating cells. 
of LTCa 
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MWOC~IOIW~ eclls (0.5-l x 10” cells) wcrc hrv~cslctl Fran 111~ ccl1 
cullurc by ccntrifuyniion (2500x 8, IQ min, daC9. clclls wcrcsuspcnd. 
ed in 50 ml of ice-cold phosphars.buffercd saline (IS0 IIIM NaCI. 5 
mM Na@osphatc, pW 7.4) and centrifuged ai 2500%~ for IO min 
SI 4OC, The resulting pcllct (nbou~ 2 ml) was dilurcd 4OJoltl with 
hypotonic bufrer (0.5 mM Na-phosphate (pH 7.O), 0.1 mM EGTA, 
and 0. I mM pl~cnylmc~liylrulfonylfl~~oridc) and yently stirred on ice 
for 3 h, The cell lysatc was subscqucmly ccnlrifuycd at IO0 OOOxg 
for 40 min at 4OC. While fluffy matcrinl around the yellowish pcllct 
Was collected and suspcntled In the same hypolonic buffer. Aftci 
homogenization with a Pottcr.Elvehjem homogcnirer (20 strokes), 
the crude membrane fraction was layered over a 38% sucrose solu. 
tion and centrifuged at 100 OOOxg for 30 min nt 4OC, The turbid 
layer at the interface was collected and diluted in 25 ml of 250 mM 
sucrose solution containing 10 mM Tris.HC1 (pH 7.4). This solution 
was cemrifuged at 100 000x g for 30 min and the resulting pellet was 
suspended in a volume of about 0.5 m1 with 250 mM sucrose and IO 
mM Tris-MCI (PM 7.4). Vesicles were formed by passing the suspen. 
sion through a 27.gauge ncedlc with a syringe, The membrane vesicles 
were finally frozen in liquid nitrogen and stored at - 70pC until USC, 
Protein was determined according to Lowry et al, [17]. The resulting 
plasma membrane vesicles exhibited a Na’+,K*-ATPase activity [IS] 
of 170 nmol*min-’ ‘mg peotein-’ with a purification factor of 
PO-fold as compared to the original cell homogenate. 
vesicles 
The standard incubaiion medium contained plasma membrane 
vesicles from mastocytoma cells (100 fig of protein), 10 nM 
[sH]leukotriens, 250 tiiM SIICIT’OS~, IO mM Tris-HCi (pN 7.4), 1 mM 
ATP, IO mM MgC12, 10 mM creatine phosphate, and 100 &ml 
creatine kinase (80 U/ml) in a final volume of 110 ,uI. The reactiorl 
was carried out at 37°C. [‘HlLeukotriene uptake was measured by 
rapid filtration as described previously [12]. 
Incubation time (min) 
Fig. 2. Time course of LTCn and LTBa uptake into plasma membrane 
vesicles from masiocytoma ceils. Membrane vesicles (100 c(g of pro- 
tein) were incubated with 10 nM [3H]LTC~ or [3H]LT13~ at 37OC in 
the absence or presence of 1 mIvl, ATP. Data are presented as the 
means rt SD (n = 3). 
Fig. 3. Lineweaver-Burk diagrams of ATP-stimulated LTC,r uptake 
into plasma metnbranc vesicles at varying concentrations of LTC4 
(A) and ATP (IS), (A) Membrane vesicles were incubated with 
[‘NJLTQ at 37°C for 5 minin the presence of I mM ATP. (B) Mem- 
brane vesicles were incubated with 10 aM [‘H]LTCa in the presence 
of varying concentrations of ATP. ATP-stimulated LTCh uptake was 
calculated from the differelxc in radioactivities incorporated into 
vesicles in the presence or absence of ATP. Data are presented as the 
means + SD (n = 3). 
the Icukotricnc biasynthesis inhibitor MK#&& and rhc 
glmthisnc Seonjugnte BNB-SO on ATE)-dependent 
LTG uptake into mntbranc vesicles. MK-571, 
LY245769, and MK-886 inhibited the uptake in a dosc- 
dependent manner with ?$I& values of less than 2 ~r!vl. 
The inhibition by BNP-SG was less effective (IC~O = 6,4 
IW, 
4. DISCUSSIQN 
An export of LTG from human eosinophils has 
recently been characterized [6], However, the underly- 
ing mcchanisrn of transport was not identified, ATP- 
dependent transport of LTC4 across plasma mcm- 
branes was originally reported by Ishikawa et al. using 
rat heart sarcolcmma and liver plasma membrane 
vesicles [l&19,20], and most recently an ATP- 
dependent transport system responsible for the 
hepatobiliary export of LTG and its metabolites has 
been identified in liver canalicular membrane [21]. Bas- 
ed on these studies it was hypothesized that an ATP- 
dependent carrier system may exist in LTGproducing 
ceils in order to mediate the release of L’TC; from the 
cells, We have examined this hypothesis using a murine 
mastocytoma cell line. LTCd as well as LTBJ are 
generated by mastocytoma cells after the stimulation 
with calcium ionophore A23187 [8,9]. As demonstrated 
in Fig. 2, plasma membrane vesicles prepared from 
mastocytoma cells exhibited ATP-dependent transport 
of LTG and LTB4. This transport is relazively specific 
for LTC4 as compared to other cysteinyl leukotrienes 
(Table I). The apparent Kiit value for LTG (1 IO nM) is 
similar to that in rat heart plasma membranes (150 nM) 
[20] and about 2-fold lower than that in rat liver 
canalicular membranes (250 nM) [21]. 
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Similes R# In pltrrma mambrunr vc.ticl@o from rat 
hem-f and liver (~0,2l], LTCd tranxparr into 
nretotocywrna vcxlcliss wm inhibited by the &mthionc 
IIP-conjugate DNWX3 (ICSO= 6.4rM). It is notcwarthy 
that rhe LTB,, resepfQ~ canfrag6xIiafb M&S71 and LY- 
247BB as well PX tRc lcukafricnc biosynthesis inhibitor 
MKJ3M inhibited the AIT-dependent ttnnsport of 
l.TG morir cffcctivcly rhrn DNP-SO (Fig. 4). These in- 
hibitors and rhe eytsinyl kukerricncs rhare the groger- 
ty of amphiphilie anions. These rcr;ults raise the 
question whether some of these compounds may exert 
their anti-inflammatory nctions not only by mtngonil;- 
in@ LTD.4 receptors or by inhibitin leukotriene biosya- 
thesis but, in additim, by inhibiting leukstricne expsr~ 
from cells such iis mast cells, eosinspkils, nncl 
monocyfes. The ATP-dependent export carrier in 
mnstocytoma cells represents n novel mcmbcr of the 
family of ATP-dependent exit pumps (22,233. The 
molecular structure and propertics of Icukorricnc 
Irvsport systems in different tisrue.s are currently 
under study in this laboratory. 
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